Intercalating of AIEgens into MoS2 Nanosheets to Induce Crystal Phase Transform for Enhanced Photothermal and Photodynamic Synergetic Anti-Tumor Therapy

Jiaxin Li,Yanzhi Xing,Xuwei Chen
DOI: https://doi.org/10.1016/j.talanta.2024.125677
IF: 6.1
2024-01-01
Talanta
Abstract:A MoS2-based nanotherapeutic platform was developed for synergetic photothermal and photodynamic antitumor therapy. AIEgens TFPy-SH molecules were intercalated into MoS2 nanosheets (MoS2 NSs) with S -deficiencies to give the nanocomposite MoS2-TFPy. The AIEgens intercalation expanded the interlayer spacing of MoS2 NSs and induced the transform of MoS2 crystal phase from 2H to 1T, offering MoS2-TFPy nanocomposite high molar absorption coefficient (5.65 L g(-1) cm (-1)), excellent photothermal conversion efficiency under nearinfrared (NIR) laser irradiation (38.3%), and favorable intracellular reactive oxygen species (ROS) generation capacity. The positively charged MoS2-TFPy were mainly distributed in mitochondria after cell up -taking, and achieved 1+1>2 anti -tumor effect attributed to its favorable photothermal and photodynamic properties. The high structure and physiological stability, favorable biocompatibility, excellent photothermal and photodynamic therapy effect make the MoS2-TFPy nanoplatform an promising candidate in biomedical clinical applications.
What problem does this paper attempt to address?